Lee Flowers's most recent trade in HCW Biologics Inc was a trade of 7,736 Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on July 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 2.59 per share. | 29 Jul 2026 | 7,736 | 8,691 | - | 2.6 | 19,998 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 07 May 2025 | 962 | 5,720 | - | 26 | 25,012 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 May 2025 | 481 | 481 | - | - | Common Stock Purchase Warrant | |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Grant, award, or other acquisition of securities at price $ 1.40 per share. | 20 Feb 2024 | 71,429 | 190,238 | - | 1.4 | 100,001 | Common Stock |
| HCW Biologics Inc | Flowers Lee | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 7,501 | 0 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Flowers Lee | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. | 08 Dec 2023 | 7,501 | 118,809 | - | 0.1 | 1,050 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 4,285 | 12,857 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. | 01 Dec 2021 | 4,285 | 95,952 | - | 0.1 | 600 | Common Stock |